Abstract
Systems biology has emerged as a major trend in biological research during the past decade. As living organisms are described in more and more detail, it aims at filling the gap between understanding basic molecular processes and complex biological systems in which new properties often emerge from the combination of these elementary processes. This approach culminates in the development of computer-based mathematical models of physiological and pathophysiological processes. We review the state of the art in dynamic modelling, with emphasis on two complementary approaches: the modelling of small systems that is mostly developed by academic teams and aims at understanding generic biological properties, and the modelling of large systems that is mostly implemented by industrial companies and aims at the generation of new therapeutic strategies. We also provide an example of such large-scale modelling applied to the identification of drug targets for neurodegeneration.
Keywords: Systems biology, models, transcriptomics, proteomics, data mining, bioinformatics
Current Pharmaceutical Design
Title: In Silico Dynamic Molecular Interaction Networks for the Discovery of New Therapeutic Targets
Volume: 16 Issue: 20
Author(s): Todor Vujasinovic, Andre Sinisa Zampera, Pascale Jackers, Despina Sanoudou and Antoine Depaulis
Affiliation:
Keywords: Systems biology, models, transcriptomics, proteomics, data mining, bioinformatics
Abstract: Systems biology has emerged as a major trend in biological research during the past decade. As living organisms are described in more and more detail, it aims at filling the gap between understanding basic molecular processes and complex biological systems in which new properties often emerge from the combination of these elementary processes. This approach culminates in the development of computer-based mathematical models of physiological and pathophysiological processes. We review the state of the art in dynamic modelling, with emphasis on two complementary approaches: the modelling of small systems that is mostly developed by academic teams and aims at understanding generic biological properties, and the modelling of large systems that is mostly implemented by industrial companies and aims at the generation of new therapeutic strategies. We also provide an example of such large-scale modelling applied to the identification of drug targets for neurodegeneration.
Export Options
About this article
Cite this article as:
Vujasinovic Todor, Sinisa Zampera Andre, Jackers Pascale, Sanoudou Despina and Depaulis Antoine, In Silico Dynamic Molecular Interaction Networks for the Discovery of New Therapeutic Targets, Current Pharmaceutical Design 2010; 16 (20) . https://dx.doi.org/10.2174/138161210791792822
DOI https://dx.doi.org/10.2174/138161210791792822 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gene-Gene and Gene-Environment Interaction on the Risk of Parkinson’s Disease
Current Aging Science N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
Current Alzheimer Research Receptors of Peptides as Therapeutic Targets in Epilepsy Research
Current Medicinal Chemistry Pharmacologic Considerations during the Preoperative Evaluation of Neurologic Patients
Current Clinical Pharmacology The Effect of Lamotrigine on Valproic Acid Concentrations
Current Drug Safety Omega-3 Fatty Acids and their Role in Central Nervous System - A Review
Current Medicinal Chemistry Review of Treatment for Cocaine Dependence
Current Drug Abuse Reviews The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators
CNS & Neurological Disorders - Drug Targets Machine Learning, Molecular Modeling, and QSAR Studies on Natural Products Against Alzheimer’s Disease
Current Medicinal Chemistry “Micromanaging” Glioblastoma Multiforme: The Potential of MicroRNAs, Circular RNAs, and the Hippo Pathway as Novel Treatment Strategies
Current Neurovascular Research Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat Refractory Panic Disorder Patient: A Case Report
CNS & Neurological Disorders - Drug Targets Characterization of the Early CNS Stress Biomarkers and Profiles Associated with Neuropsychiatric Diseases
Current Genomics Adult Stem Cell Application in Spinal Cord Injury
Current Drug Targets Cell-based Treatment of Cerebral Palsy: Still a Long Way Ahead
Current Stem Cell Research & Therapy Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer’s Disease
Current Topics in Medicinal Chemistry Bioactive Compounds in Some Culinary Aromatic Herbs and Their Effects on Human Health
Mini-Reviews in Medicinal Chemistry Neuropsychiatric Systemic Lupus Erythematosus
Current Neuropharmacology Recent Advancement in Computer-Aided Drug Design
Current Pharmaceutical Design Editorial [Hot Topic: Adenosine-Based Modulation of Brain Activity (Guest Editor: DETLEV BOISON)]
Current Neuropharmacology Association and Causal Relationship of Midlife Obesity and Related Metabolic Disorders with Old Age Cognition
Current Alzheimer Research